Home Our Company Additional Resurces Publications Contact

Study Suggests New Way to Prevent Vision Loss in Diabetics and Premature Babies
March 21, 2017-The Rockefeller University Press

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy
April 3, 2017-Journal of Experimental Medicine

 

 

© Copyright Everglades Biopharma. All rights reserved.